Home/Filings/4/0001209191-19-024375
4//SEC Filing

VASCONCELLES MICHAEL 4

Accession 0001209191-19-024375

CIK 0001622229other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:39 PM ET

Size

5.6 KB

Accession

0001209191-19-024375

Insider Transaction Report

Form 4
Period: 2019-03-01
VASCONCELLES MICHAEL
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-03-01+61,90061,900 total
    Exercise: $4.36Exp: 2029-03-01Common Stock (61,900 underlying)
Footnotes (1)
  • [F1]25% of the shares vests on March 1, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.

Issuer

Unum Therapeutics Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001734755

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:39 PM ET
Size
5.6 KB